This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Smoking Cessation

Nalmefene Smoking Cessation Study

Sponsored by Somaxon Pharmaceuticals

About this trial

Last updated 17 years ago

Study ID

SP-N0408

Status

Completed

Type

Interventional

Phase

Phase 2

Placebo

Yes

Accepting

18-75 Years
25 to 65 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 19 years ago

What is this trial about?

To determine if nalmefene is safe and effective in smoking cessation.

What are the participation requirements?

Yes

Inclusion Criteria

- Smokers in good general health self reporting more than 15 cigarettes per day

Locations

Location

Status